Concurrent Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patient Treated With Daratumumab and Tafamidis: A Case Report

Abstract Immunoglobulin light chain (AL) and wild‐type transthyretin (ATTRwt) amyloidosis, while sharing similar clinical presentations, require distinct treatments. We report a rare case of a 75‐year‐old man with heart failure diagnosed with concurrent AL and ATTRwt cardiac amyloidosis. Immunohisto...

Descripció completa

Dades bibliogràfiques

Autors principals:	Taiki Nishihara, Yawara Kawano, Masayoshi Tasaki, Ayuko Naito, Hiromichi Yuki, Yasuhiro Nagayoshi, Seiji Takashio, Nao Nishimura, Mitsuharu Ueda, Kenichi Tsujita, Jun‐Ichirou Yasunaga
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2025-08-01
Col·lecció:	eJHaem
Matèries:	AL amyloidosis ATTR amyloidosis case report daratumumab tafamidis
Accés en línia:	https://doi.org/10.1002/jha2.70122
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!